Immunology/Virology Research / Medco Research Institute

Research Areas

Current Research Studies

Frequent Recurrence Obviated by Suppressive Therapy (FROST)

Research to Evaluate the Cost Effectiveness of Interventions with Prescriptions of Thiopurines (RECEIPT)

Novel Interventions in Methotrexate Boosts Levels of Effectiveness (NIMBLE)

Archived Research Studies

Novel Methodology to Measure Adherence to Complex Medication Regimens in HIV/AIDS Patients

Retrospective Review of Erythropoiesis Stimulating Agent (ESA) Use Reveals Physicians Adhering to FDA Warnings

Adherence as a Predictor of the Utilization of Healthcare Resources in a Multiple Sclerosis Population Using Interferons

Relationship Between Adherence to Interferons to Treat Multiple Sclerosis and the Number and Severity of Relapses

Tolerability of Intravenously Administered Immune Globulin in the Home Setting

Exploring the Impact of Dispensing Channel on Medication Adherence Among Multiple Sclerosis Patients

Author Perspectives

Bryan Dechairo, PhD

Senior Director, Extramural R&D Head
Medco Research Institute

Dr. Bryan Dechairo joined Medco in January 2009 as the head of Extramural Research and Development for the Medco Research Institute. In this role, Dr Dechairo translates clinically valid tools into widely accessible and effective medical and pharmacy practice innovations that improve health outcomes for Medco members and decrease the cost of healthcare for Medco clients. Additionally, Dr Dechairo is responsible for business development and strategic alliances which impact Medco’s healthcare innovation pipeline from research through commercial.